Text message advice could keep kids with fever out of the ER
NCT ID NCT07248488
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving parents standardized fever advice during an emergency call plus a follow-up text message can reduce unnecessary doctor visits and ER trips for children aged 3 months to 10 years with uncomplicated fever. About 1,792 parents will be randomly assigned to receive either usual care or the enhanced advice and text message. The goal is to see if this simple, low-cost intervention improves how parents manage fever and reduces strain on the healthcare system.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- standardized recommendations and advisory text message
- What this could lead to
- If successful, this low-cost approach could reduce unnecessary emergency visits and help parents manage childhood fever at home more confidently.
- What could go wrong
- This is a relatively small, early-stage trial. The effect may be modest, and results might not apply to all regions or healthcare systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,792 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria relating to the child concerned by the call to the SAMU Centre 15: * Call for a child aged between 3 months and 10 years, * Presenting with fever alone (SFMU/GPIP definition), * Developing for less than 72 hours, * Without clinical signs, * And without signs of seriousness requiring emergency medical attention (as determined by SAMU Centre 15): * Fever ≥41°C, * Impaired consciousness, * Convulsions, * Dyspnea, * Skin rash, * Dehydration. Inclusion criteria relating to the caller: * Caller with parental authority over the child concerned by the call, * Affiliated to a social security scheme or beneficiary of a similar scheme. Exclusion criteria relating to children involved in calls to the SAMU Centre 15 emergency medical service: * Children who have already been the subject of a call to the SAMU Centre 15 emergency medical service in the last 15 days, * Children with a history of urinary tract infection, * Children referred by the dispatcher during the phone call to a healthcare facility for clinical evaluation (SMUR, private ambulance, fire department, parents referred to the emergency room or primary care physician). Exclusion criteria relating to the caller: * Calls made from a landline or foreign number, making it impossible to send text messages, * Calls made by someone who cannot read or understand French.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Emergency call are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CH Annecy Genevois
Annecy, Auvergne-Rhône-Alpes, 74370, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.